Oligonucleotides for modulation of target RNA activity

Details for Australian Patent Application No. 2008261404 (hide)

Owner Mirx Therapeutics ApS

Inventors Moller, Thorleif

Agent FB Rice

Pub. Number AU-A-2008261404

PCT Pub. Number WO2008/151639

Priority PA 2007 01493 16.10.07 DK; PA 2008 00214 15.02.08 DK; PA 2007 00860 14.06.07 DK; PA 2007 01725 03.12.07 DK; PA 2007 01580 09.11.07 DK; PA 2007 01504 18.10.07 DK

Filing date 13 June 2008

Wipo publication date 18 December 2008

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61P 31/14 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

14 January 2010 PCT application entered the National Phase

  PCT publication WO2008/151639 Priority application(s): WO2008/151639

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008261419-Method and device for controlling power car window lift

2008261403-A hearing aid system for establishing a conversation group